Moderna, Inc. (NASDAQ:MRNA) | WebDisclosure

Basculer en Français

8315	Companies
116037	Keywords
56026	Articles
62866	Press releases

Home
Companies
Moderna, Inc.

BRIEF

published on 04/24/2024 at 14:05, 7 months 2 days ago

Moderna Collaborates with OpenAI to Enhance mRNA Medicines Using Advanced AI

Healthcare Innovation MRNA Technology Moderna OpenAI AI Collaboration
BRIEF

published on 04/24/2024 at 14:05, 7 months 2 days ago

Moderna collabore avec OpenAI pour améliorer les médicaments à ARNm grâce à l'IA avancée

Technologie ARNm Innovation En Matière De Soins De Santé Moderne OpenAI Collaboration IA
PRESS RELEASE

published on 04/24/2024 at 14:00, 7 months 2 days ago

Moderna and OpenAI Collaborate To Advance mRNA Medicine
Moderna and OpenAI collaborate to integrate generative AI tools, like ChatGPT Enterprise, into operations to enhance AI culture and augment employee roles for maximum impact on patients

Generative AI Machine Learning Moderna OpenAI ChatGPT Enterprise
BRIEF

published on 04/17/2024 at 13:05, 7 months 9 days ago

Moderna to Present Q1 2024 Financial Results in May

Financial Results Conference Call Webcast Moderna Q1 2024
BRIEF

published on 04/17/2024 at 13:05, 7 months 9 days ago

Moderna présentera ses résultats financiers du premier trimestre 2024 en mai

Résultats Financiers Webdiffusion Conférence Téléphonique Moderne T1 2024
PRESS RELEASE

published on 04/17/2024 at 13:00, 7 months 9 days ago

Moderna to Report First Quarter 2024 Financial Results on Thursday, May 2, 2024
Moderna, Inc. will host a live conference call to report Q1 2024 financial results and provide a corporate update. Moderna is a leader in mRNA medicine revolutionizing disease treatment

Financial Results Conference Call Corporate Update Moderna Inc. MRNA Medicine
BRIEF

published on 04/03/2024 at 17:05, 7 months 22 days ago

Moderna's mRNA Therapy for Propionic Acidemia Shows Promise in Early-Stage Trial

Gene Therapy Clinical Trial Moderna MRNA Therapy Propionic Acidemia
BRIEF

published on 04/03/2024 at 17:05, 7 months 22 days ago

La thérapie par ARNm de Moderna pour l'acidémie propionique s'avère prometteuse lors d'un essai à un stade précoce

Essai Clinique Thérapie Génique Moderne Thérapie Par ARNm Acidémie Propionique
PRESS RELEASE

published on 04/03/2024 at 17:00, 7 months 22 days ago

Phase 1/2 Interim Data on Moderna’s mRNA-3927, an Investigational mRNA Therapy for Propionic Acidemia, Published in Nature
Moderna, Inc. announced interim data for mRNA-3927 therapy for propionic acidemia published in Nature, showing signs of clinical benefit and safety. Ongoing global trial evaluates safety and efficacy in participants with PA

Clinical Trial Moderna Propionic Acidemia MRNA-3927 Genetic Disorder
BRIEF

published on 03/27/2024 at 11:35, 7 months 30 days ago

Moderna Announces Significant Advancements in Vaccine Development Programs

COVID-19 MRNA Technology Moderna Vaccine Development Phase 3 Clinical Trials

Accesswire

Published on 11/26/2024 at 15:30, 12 minutes ago

Renewance Partners With U.S. Department of Labor to Launch Registered Apprenticeship Program for Skilled Battery Technicians
Published on 11/26/2024 at 15:15, 27 minutes ago

Kingstone Insurance Partners with Earnix to Improve Pricing Sophistication and Speed to Market
Published on 11/26/2024 at 15:00, 42 minutes ago

BluWave-ai Completes Canada's First AI-Driven, Multiple EV OEM Demand Response Events to Support Electrical System at Hydro Ottawa
Published on 11/26/2024 at 15:00, 42 minutes ago

Route1 Announces Q3 2024 Financial Results
Published on 11/26/2024 at 14:30, 1 hour 12 minutes ago

LQR House Inc. Elevates SWOL Tequila With Sleek New Bottle Design and Exclusive Golden Ticket Campaign

View all ACCESSWIRE

EQS Group

Published on 11/26/2024 at 15:29, 13 minutes ago

Form 8.3 - The Vanguard Group, Inc.: International Paper Company
Published on 11/26/2024 at 15:28, 13 minutes ago

Form 8.3 - The Vanguard Group, Inc.: TI Fluid Systems plc
Published on 11/26/2024 at 15:27, 14 minutes ago

Form 8.3 - The Vanguard Group, Inc.: International Distribution Services plc
Published on 11/26/2024 at 15:26, 16 minutes ago

Form 8.3 - The Vanguard Group, Inc.: Hargreaves Lansdown plc
Published on 11/26/2024 at 15:25, 17 minutes ago

Form 8.3 - The Vanguard Group, Inc.: Britvic plc

Les Echos

Published on 11/26/2024 at 08:30, 7 hours 12 minutes ago

Cie du Bois Sauvage: Terugkoop van eigen aandelen – Week van 18/11/2024 tot 22/11/2024
Published on 11/26/2024 at 08:30, 7 hours 12 minutes ago

Cie du Bois Sauvage : Rachat d’actions propres – semaine du 18/11/2024 au 22/11/2024
Published on 11/26/2024 at 08:30, 7 hours 12 minutes ago

Cie du Bois Sauvage: Buy back of own shares – week from 18/11/2024 to 22/11/2024
Published on 11/26/2024 at 07:57, 7 hours 45 minutes ago

Neoen and Equinix sign their first PPA in Italy supporting decarbonization of the local grid
Published on 11/26/2024 at 07:57, 7 hours 45 minutes ago

Neoen et Equinix signent leur premier PPA en Italie en faveur de la décarbonation du réseau électrique

View all LES ECHOS COMFI WIRE